The estimated Net Worth of Jonathan Garen is at least $584 millier dollars as of 3 January 2018. Jonathan Garen owns over 5,864 units of uniQure N.V stock worth over $466,323 and over the last 8 years Jonathan sold QURE stock worth over $118,042.
Jonathan has made over 1 trades of the uniQure N.V stock since 2018, according to the Form 4 filled with the SEC. Most recently Jonathan sold 5,864 units of QURE stock worth $118,042 on 3 January 2018.
The largest trade Jonathan's ever made was selling 5,864 units of uniQure N.V stock on 3 January 2018 worth over $118,042. On average, Jonathan trades about 1,466 units every 0 days since 2017. As of 3 January 2018 Jonathan still owns at least 85,251 units of uniQure N.V stock.
You can see the complete history of Jonathan Garen stock trades at the bottom of the page.
Jonathan's mailing address filed with the SEC is C/O UNIQURE N.V., PAASHEUVELWEG 25A, AMSTERDAM, P7, 11058BP.
Over the last 8 years, insiders at uniQure N.V have traded over $35,572,573 worth of uniQure N.V stock. The most active insiders traders include Deventer Sander Van, Paula Soteropoulos et William Lewis. On average, uniQure N.V executives and independent directors trade stock every 14 days with the average trade being worth of $37,634. The most recent stock trade was executed by Walid Abi Saab on 26 June 2024, trading 1,447 units of QURE stock currently worth $6,309.
uniqure is delivering on the promise of gene therapy - single treatments with potentially curative results. we are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.
uniQure N.V executives and other stock owners filed with the SEC include: